Effects of statins on kidney function in older adults
Open Access
- 18 December 2024
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (4) , 1082-1093
Abstract
Background: The effect of statin therapy on kidney function among older adults is unclear. Objectives: To examine the association between statin use and changes in estimated glomerular filtration rate (eGFR) and urine albumin‐to‐creatinine ratio (UACR), positive or negative, in an older adult cohort with versus without chronic kidney disease (CKD) at baseline. Methods: This analysis included 18,056 participants aged ≥65 years with versus without CKD at baseline in a randomized trial of low‐dose aspirin, who had no prior cardiovascular events, major physical disability, or dementia initially. Outcome measures included eGFR and UACR. Linear mixed‐effects models were used to estimate the associations of baseline statin use versus no use with eGFR and UACR changes over time. The inverse‐probability of treatment‐weighting technique was used for all analyses to address confounding by indication due to the lack of randomization in treatment assignment. Results: Statin use was not associated with change in eGFR, UACR, or incident CKD in participants with or without CKD at baseline ( p > 0.05 for all associations). Subgroup analyses found no significant interactions between statin and age, sex, diabetes, country, and frailty status on any of the study outcomes. Conclusions: Among adults ≥65 years of age, with and without CKD, statin therapy was not associated with improved or worsened kidney function. This data suggests that the decision to use versus not use statins in this population may be ideally guided by factors other than kidney health.Keywords
Funding Information
- National Health and Medical Research Council (1127060, 334047)
- National Institute on Aging
- National Cancer Institute (U01AG029824, U19AG062682)
- Monash University
This publication has 18 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly – eXTension (ASPREE-XT) Observational StudyContemporary Clinical Trials, 2023
- Pragmatic evaluation of events and benefits of lipid lowering in older adults ( PREVENTABLE ): Trial design and rationaleJournal of the American Geriatrics Society, 2023
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysisRenal Failure, 2021
- Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older AdultsJACC, 2020
- Effect of Aspirin on Disability-free Survival in the Healthy ElderlyNew England Journal of Medicine, 2018
- Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyNew England Journal of Medicine, 2018
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy ElderlyNew England Journal of Medicine, 2018
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005